Illinois health officials confirm two measles cases in Cook County
April 30 (Reuters) - The Chicago Department of Public Health and Cook County Department of Public Health on Wednesday confirmed two measles cases in Cook County.
These are the first two cases in Cook County, Illinois, this year.
Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.
One case was identified as an adult who is a suburban Cook County resident, and whose vaccination status is unknown.
Another case was identified in an adult Chicago resident who traveled internationally through O'Hare Airport in early April.
The patient, who had one prior dose of the measles vaccine, had a rash that started on April 25 and has been isolated at home since being diagnosed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
39 minutes ago
- Reuters
Ukraine and Russia exchange wounded, ill prisoners of war
KYIV, June 12 (Reuters) - Ukraine and Russia exchanged another group of ill and severely wounded servicemen on Thursday, officials from both countries said. All of the Ukrainian troops need treatment, Ukraine's President Volodymyr Zelenskiy said in a message on the Telegram messaging app that did not go into details on the numbers involved. Kyiv and Moscow agreed to a large exchange of POWs and the remains of thousands of dead soldiers during talks in Istanbul earlier this month. Since then, Russia and Ukraine have swapped dozens of prisoners of war, focusing on under-25s and the severely wounded and sick. There are hopes they could build into some of the biggest exchanges in the war that was triggered by Russia's 2022 invasion of Ukraine. Russia's defence ministry said a group of Russian troops had returned from Ukraine and crossed into neighbouring Belarus, in accordance with the agreements made on June 2. "They are being provided with the necessary psychological and medical assistance," the ministry said on Telegram. On Wednesday, Ukraine said it had brought home the bodies of 1,212 bodies of troops killed in the war with Russia. Kremlin aide Vladimir Medinsky said Ukraine had returned the bodies of 27 Russian soldiers.
Reuters
an hour ago
- Reuters
Colombian senator Uribe still in critical condition five days after shooting
BOGOTA, June 12 (Reuters) - Colombian Senator Miguel Uribe, a potential presidential contender, remains in critical but stable condition after being shot in Bogota on Saturday, the hospital treating him said on Thursday. Physicians continue to work to mitigate the impact of the injuries, the Santa Fe Foundation hospital said in a statement.
Scottish Sun
2 hours ago
- Scottish Sun
‘Game changing' fat jabs WON'T help you lose as much weight as you think, scientists discover
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) SO-CALLED 'miracle' weight-loss jabs are far less effective in the real world than in clinical trials, a major study has revealed. The new findings could have big implications for Brits considering the injections, which have soared in popularity across the UK in recent years. Sign up for Scottish Sun newsletter Sign up 2 In a 'real-world' setting people might lose less weight in a regular clinical setting than during clinical trials Credit: Alamy 2 The drugs work best when people stick to them and take the full recommended dose Credit: Reuters Until now, the jabs have been hailed as an easier alternative to classic weight loss methods like calorie counting, weight watchers and the gym. But researchers at the Cleveland Clinic in the US found average weight loss on the jabs in the 'real world' is just 6.9 per cent after a year. This is less than half the amount typically seen in clinical trials, where patients often lose 15 per cent with semaglutide, the ingredient in Wegovy, and up to 22.5 per cent with tirzepatide, found in Mounjaro. The study, published on Tuesday in Obesity, followed 7,881 adults with severe obesity who started semaglutide or tirzepatide between 2021 and 2023. It discovered the drugs worked best when people stuck to them and took the full recommended dose, but in the real world, that rarely happened. More than one in five patients (21 per cent) stopped taking the jabs within the first three months, and another 32 per cent quit between three and 12 months. Meanwhile, over 80 per cent were on lower-than-recommended maintenance doses, needed to keep the weight off. Those who quit early lost just 3.6 per cent of their body weight. Patients who stayed on the treatment for a full year lost 11.9 per cent on average. The best results were seen in people who stayed on full doses, who lost 13.7 per cent with semaglutide and 18 per cent with tirzepatide. GP-approved tips to really lose weight safely - and keep it off 'Our findings could inform the decisions of healthcare providers and their patients on the role of treatment discontinuation and maintenance dosage in achieving clinically meaningful weight reductions," Dr Hamlet Gasoyan, lead author of the study, said. Among the 1,320 people with prediabetes, the precursor to type 2 diabetes, at the start of the study, those who stayed on the jabs were also far more likely to reverse the condition. Don't stop the drugs early These medications work by copying a natural hormone found in the body called GLP-1. This hormone helps people feel fuller for longer, which reduces appetite and helps with weight loss. It also helps control blood sugar by telling the pancreas to make more insulin and slowing down how quickly sugar from food gets into the bloodstream. That's why these drugs are effective at both preventing type 2 diabetes and helping people shed pounds. Just 33 per cent of early quitters returned to normal blood sugar levels, compared with 68 per cent of those who stayed on the medication. 'Type 2 diabetes is one of the most common complications of obesity, so diabetes prevention is very important,' Dr Gasoyan said. 'This study highlights that treatment discontinuation, especially early, negatively affects both weight and glycemic control outcomes.' The most common reasons for stopping the jabs were cost, insurance issues, side effects and shortages, it said, The experts said a follow-up study is planned to dig deeper into why patients quit, and what happens to their weight afterwards.
